Influenza Congress USA is the leading commercially-focused influenza conference in North America

The 4th annual Influenza Congress USA is where key decision makers from pharma, biotech and government come together to plan their development strategies and share best practice with their peers in ‘flu vaccine manufacture.

Last year, we had senior executives from GSK, Novartis, Sanofi Pasteur, CSL and over 100 other companies discussing adjuvant approval in the US, universal vaccine development, cell-based vaccine development, biotech partnering and funding, delivery, experimental challenge studies and novel egg-based vaccine manufacturing.

 
 Influenza  Congress USA is the only commercially-focused industry event for pharma, biotech, universities and investors.
 
 
 This year influenza industry experts will once again gather to get updates and discover strategies on the most important issues

Come to Influenza Congress USA and learn:

  • How to grow business in light of current developments – H5N1, adjuvant approval, cell-based vaccine commercialization, low volume manufacturing
  • How to navigate regulatory compliance
  • How to fast track FDA approval
  • How to monetize new discoveries sooner
  • How to eliminate research and manufacturing bottlenecks
  • How to attract investment and funding
  • How to choose partners
  • How to identify the most cost-effective technologies

Can you afford not to be here?

 
sponsorship opportunities at Influenza Congress USA speaking opportunities at Influenza Congress USA

download the Influenza Congress USA brochure register for Influenza Congress USA now
 

Influenza Congress USA is where world class healthcare solutions providers attend:

  • To meet senior-level decision makers from leading government agencies, pharmaceutical  and biotechnology companies
  • To showcase their expertise and experience
  • To position and maintain their brand as a leader in the fight against influenza
  • To generate leads and new business

Influenza Congress USA offers:

  • A high impact, interactive platform – designed to maximize the business experience for participants
  • An outstanding opportunity for high-value solutions vendors to demonstrate products, make sales and increase their profile
  • A showcase of world-class investors & providers of products and services

Last year's speakers included:

  • Dr. Robert Huebner, US DHHS
  • Dr. Stephen Redd, Centers for Disease Control and Prevention
  • Dr. Norman Baylor, FDA 
  • Martine Wettendorff, GSK
  • Philip Dormitzer, Novartis Vaccines & Diagnostics
  • Dr. Debbie Drane, CSL Biotherapies
  • Dr. Maja Sommerfelt, Bionor Pharma
  • Vincent Serra, Wittycell

 

Industry news